Live Breaking News & Updates on Nandini piramal

Stay informed with the latest breaking news from Nandini piramal on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Nandini piramal and stay connected to the pulse of your community

Business Today's 19th MPW event honours star performers in Business

Business Today's 19th MPW event honours star performers in Business

United-states , India , Mumbai , Maharashtra , America , Arundhati-bhattacharya , Jhulan-goswami , Nita-ambani , Zia-mody , Ghazal-alagh , Roshni-nadar-malhotra , Swati-piramal

MPW 2022 honours Ghazal Alagh, Roshni Nadar, Vineeta Singh and other star performers in business

The finest women achievers in business were felicitated at BT MPW's 19th edition by chief guest Smriti Irani, Union Minister of Women & Child Development and Minister of Minority Affairs

United-states , Mumbai , Maharashtra , India , America , Suman-mishra , Jemimah-rodrigues , Hrishikesh-kanitkar , Roshni-nadar-malhotra , Zia-mody , Masaba-gupta , Ameera-shah

Piramal Pharma Limited Announces Consolidated Results for Q3 and 9M FY2023

/PRNewswire/ -- Piramal Pharma Limited (NSE: PPLPHARMA) (BSE: 543635), today announced its consolidated results for the third quarter (Q3) and nine month (9M)...

New-york , United-states , Mumbai , Maharashtra , India , Hong-kong , United-kingdom , Singapore , Ahmedabad , Gujarat , Riverview , London

Piramal Pharma Ltd: Piramal Pharma Limited Announces Consolidated Results for Q3 and 9M FY2023

MUMBAI, India, Feb. 8, 2023 /PRNewswire/ -- Piramal Pharma Limited (NSE: PPLPHARMA) (BSE: 543635), today announced its consolidated results for the third quarter (Q3) and nine month (9M) ended

New-york , United-states , Mumbai , Maharashtra , India , Hong-kong , United-kingdom , Singapore , Ahmedabad , Gujarat , Riverview , London

Piramal Pharma Limited Announces Consolidated Results for Q3 and 9M FY2023

/PRNewswire/ -- Piramal Pharma Limited (NSE: PPLPHARMA) (BSE: 543635), today announced its consolidated results for the third quarter (Q3) and nine month (9M)...

New-york , United-states , Mumbai , Maharashtra , India , Hong-kong , United-kingdom , Singapore , Ahmedabad , Gujarat , Riverview , London

Piramal Pharma Limited Announces Consolidated Results for Q2 and H1 FY2023

/PRNewswire/ -- Piramal Pharma Limited (NSE: PPLPHARMA) (BSE: 543635), a leading global pharmaceuticals company, today announced its consolidated results for...

Germany , Mumbai , Maharashtra , India , Nandini-piramal , Piramal-pharma , Contract-development , Hemmo-pharmaceuticals-pvt-ltd , Twitter , Piramal-pharma-limited , Piramal-pharma-ltd , Carlyle-group

Q2 Results Piramal Pharma Registers Loss Of Rs 37 Cr EBITDA Rises By 2 2

Latest Indian Business News on BW Businessworld, Analysis of Indian Economy by Experts

Nandini-piramal , Piramal-pharma , Second-quarter , Half-year , Stock-keeping-unit , Business-news-in-india , Ndian-business-news , Atest-business-news ,

Latest News | Piramal Pharma Posts Net Loss of Rs 37 Cr in Q2

Get latest articles and stories on Latest News at LatestLY. Piramal Pharma on Wednesday reported a consolidated net loss of Rs 37 crore for the second quarter ended September, as against a net profit of Rs 37 crore in the year-ago period.
Latest News | Piramal Pharma Posts Net Loss of Rs 37 Cr in Q2.

New-delhi , Delhi , India , Nandini-piramal , Piramal-pharma , Hemmo-pharmaceuticals-pvt-ltd , National-company-law-tribunal , Convergence-chemical-pvt-ltd , Piramal-pharma-ltd , Piramal-enterprises-ltd , Piramal-pharma-limited ,

Piramal Pharma to invest Rs1,200 in UK over the next 12 to 18 months

In a recent interview with ET, Piramal Pharma chair Nandini Piramal stated that the business would invest Rs1,200 crore in antibody-drug conjugate capacity at Grangemouth, in UK, over the course of the following 12 to 18 months.

India , United-kingdom , Grangemouth , Falkirk , Nandini-piramal , Piramal-pharma , Piramal-pharma-solutions , Carlyle-group , Critical-care ,

Piramal Pharma Limited Lists on BSE and NSE

Piramal Pharma Limited (PPL) (Scrip Name: PPLPHARMA) today listed on the Indian stock exchanges, Bombay Stock Exchange (BSE) and National Stock Exchange (NSE). The milestone was marked with the ringing of the opening bell at BSE to announce the listing by Mr. Ajay Piramal, Chairman of Piramal Group, Ms. Nandini Piramal, Chairperson of PPL, and Mr. Peter DeYoung, CEO, Piramal

India , Bombay , Maharashtra , Nandini-piramal , Piramal-pharma , Peter-deyoung , Sameer-patil , Ajay-piramal , Nayan-mehta , Manufacturing-organisation , Contract-development , Piramal-pharma-limited